Revivent TC

DEVICE2 trials

Sponsors

BioVentrix

Conditions

Heart FailureVentricular Dysfunction, Left

Phase 1

Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy

CompletedNCT02553785

BioVentrixHeart Failure

Start: 2015-06-30End: 2019-12-31Target: 89Updated: 2021-03-12

Unknown Phase

BioVentrix Revivent TC™ System Clinical Study

Active, not recruitingNCT02931240

BioVentrixVentricular Dysfunction, Left

Start: 2017-08-29End: 2027-06-30Target: 126Updated: 2023-08-22

Related Papers

Transcatheter Left Ventricular Reconstruction in Heart Failure Patients With Prior Anterior Myocardial Infarction: The Prospective ALIVE Trial.

2025-01-081 citations

Editorial introductions

Current Opinion in Cardiology2024-02-06

Editorial introductions

Current Opinion in Cardiology2023-01-31